Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia

被引:56
作者
Biadgilign, Sibhatu [2 ]
Deribew, Amare [2 ]
Amberbir, Alemayehu [3 ]
Deribe, Kebede [1 ]
机构
[1] Fayyaa Integrated Dev Assoc NCMI, PEPFAR New Partners Initiat, Addis Ababa, Ethiopia
[2] Jimma Univ, Publ Hlth Fac, Dept Epidemiol & Biostat, Jimma, Ethiopia
[3] Univ Addis Ababa, Sch Publ Hlth, Butajira Birth Cohort Project, Addis Ababa, Ethiopia
关键词
D O I
10.1186/1471-2431-8-53
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The introduction of combination antiretroviral therapy (ART) has resulted in striking reductions in HIV-related mortality. Despite increased availability of ART, children remain a neglected population. This may be due to concerns that failure to adhere appears to be related to continued viral replication, treatment failure and the emergence of drug-resistant strains of HIV. This study determines the rates and factors associated with adherence to Antiretroviral (ARV) Drug therapy in HIV-infected children who were receiving Highly Active Antiretroviral Therapy (HAART) in Addis Ababa, Ethiopia in 2008. Methods: A cross-sectional study was conducted in five hospitals in Addis Ababa from February 18-April 28, 2008. The study population entailed parents/caretaker and index children who were following ART in the health facilities. A structured questionnaire was used for data collection. Results: A total of 390 children respondents were included in the study with a response rate of 91%. The majority, equaling 205 (52.6%) of the children, were greater than 9 years of age. Fifty five percent of the children were girls. A total of 339 children (86.9%) as reported by caregivers were adherent to antiretroviral drugs for the past 7 days before the interview. Numerous variables were found to be significantly associated with adherence: children whose parents did not pay a fee for treatment [OR = 0.39 (95% CI: 0.16, 0.92)], children who had ever received any nutritional support from the clinic [OR = 0.34 ( 95% CI: 0.14, 0.79)] were less likely to adhere. Whereas children who took co-trimoxazole medication/syrup besides ARVs [OR = 3.65 ( 95% CI: 1.24, 10.74)], children who did not know their sero-status [OR = 2.53 ( 95% CI: 1.24, 5.19)] and children who were not aware of their caregiver's health problem [OR = 2.45 ( 95% CI: 1.25, 4.81)] were more likely to adhere than their counterparts. Conclusion: Adherence to HAART in children in Addis Ababa was higher than other similar setups. However, there are still significant numbers of children who are non-adherent to HAART.
引用
收藏
页数:9
相关论文
共 49 条
  • [1] ANGEVINE R, APHA 135 ANN M EXP W
  • [2] Disclosure model for pediatric patients living with HIV in Puerto Rico: Design, implementation, and evaluation
    Blasini, I
    Chantry, C
    Cruz, C
    Ortiz, L
    Salabarria, I
    Scalley, N
    Matos, B
    Febo, I
    Diaz, C
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2004, 25 (03) : 181 - 189
  • [3] BONI S, 2000, INT J ANTIMICROB AG, V16, P682
  • [4] Byrne Mary, 2002, AIDS Read, V12, P151
  • [5] Decreased needs for hospital care and antibiotics in children with advanced HIV-1 disease after protease inhibitor-containing combination therapy
    Canani, RB
    Spagnuolo, MI
    Cirillo, P
    Guarino, A
    [J]. AIDS, 1999, 13 (08) : 1005 - 1006
  • [6] CONNOR EM, 1993, PEDIATR INFECT DIS J, V12, P513, DOI 10.1097/00006454-199306000-00011
  • [7] Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection
    de Martino, M
    Tovo, PA
    Balducci, M
    Galli, L
    Gabiano, C
    Rezza, G
    Pezzotti, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02): : 190 - 197
  • [8] Desiree M, 2006, EXPLORING CURRENT PR
  • [9] A randomized trial of multivitamin supplements and HIV disease progression and mortality
    Fawzi, WW
    Msamanga, GI
    Spiegelman, D
    Wei, RL
    Kapiga, S
    Villamor, E
    Mwakagile, D
    Mugusi, F
    Hertzmark, E
    Essex, M
    Hunter, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) : 23 - 32
  • [10] Protease inhibitor therapy in HIV-infected children
    Feingold, AR
    Rutstein, RM
    Meislich, D
    Brown, T
    Rudy, BJ
    [J]. AIDS PATIENT CARE AND STDS, 2000, 14 (11) : 589 - 593